143 related articles for article (PubMed ID: 30993764)
1. Disparities in the management of cutaneous malignant melanoma. A population-based high-resolution study.
Guevara M; Rodríguez-Barranco M; Puigdemont M; Minicozzi P; Yanguas-Bayona I; Porras-Povedano M; Rubió-Casadevall J; Sánchez Pérez MJ; Marcos-Gragera R; Ardanaz E
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13043. PubMed ID: 30993764
[TBL] [Abstract][Full Text] [Related]
2. Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands.
Verstijnen J; Damude S; Hoekstra HJ; Kruijff S; Ten Tije AJ; Louwman WJ; Bastiaannet E; Stuiver MM
Surg Oncol; 2017 Dec; 26(4):431-437. PubMed ID: 29113662
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
[TBL] [Abstract][Full Text] [Related]
4. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
Ann Surg Oncol; 2019 May; 26(5):1494-1502. PubMed ID: 30719636
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
6. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
9. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
Wasif N; Gray RJ; Bagaria SP; Pockaj BA
Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
11. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
13. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node biopsy in melanoma: our experience over 8 years in a universitary hospital].
Bañuelos-Andrío L; Rodríguez-Caravaca G; López-Estebaranz JL; Rueda-Orgaz JA; Pinedo-Moraleda F
Cir Cir; 2015; 83(5):378-85. PubMed ID: 26141108
[TBL] [Abstract][Full Text] [Related]
15. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
17. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
18. Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.
Martinez SR; Shah DR; Maverakis E; Yang AD
J Surg Oncol; 2012 Dec; 106(7):807-10. PubMed ID: 22674455
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the use of sentinel lymph node biopsy in the Netherlands.
Huismans AM; Niebling MG; Wevers KP; Schuurman MS; Hoekstra HJ
Ann Surg Oncol; 2014 Oct; 21(11):3395-400. PubMed ID: 24819123
[TBL] [Abstract][Full Text] [Related]
20. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
